0001493152-23-024899.txt : 20230719 0001493152-23-024899.hdr.sgml : 20230719 20230719120006 ACCESSION NUMBER: 0001493152-23-024899 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230712 FILED AS OF DATE: 20230719 DATE AS OF CHANGE: 20230719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waldman Lawrence CENTRAL INDEX KEY: 0001516592 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31885 FILM NUMBER: 231096072 MAIL ADDRESS: STREET 1: 5115 ULMERTON RD. CITY: CLEARWATER STATE: FL ZIP: 33770 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apyx Medical Corp CENTRAL INDEX KEY: 0000719135 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112644611 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5115 ULMERTON ROAD CITY: CLEARWATER STATE: FL ZIP: 33760 BUSINESS PHONE: 7273842323 MAIL ADDRESS: STREET 1: 5115 ULMERTON ROAD CITY: CLEARWATER STATE: FL ZIP: 33760 FORMER COMPANY: FORMER CONFORMED NAME: BOVIE MEDICAL Corp DATE OF NAME CHANGE: 20150319 FORMER COMPANY: FORMER CONFORMED NAME: BOVIE MEDICAL CORP DATE OF NAME CHANGE: 19990216 FORMER COMPANY: FORMER CONFORMED NAME: AN CON GENETICS INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0508 4 2023-07-12 0 0000719135 Apyx Medical Corp APYX 0001516592 Waldman Lawrence C/O APYX MEDICAL CORPORATION 5115 ULMERTON ROAD CLEARWATER FL 33760 1 0 0 0 0 Common Stock 2023-07-12 4 M 0 5338 2.97 A 5338 I By SLAT Common Stock 37563 D Stock Option (Option to Buy) 2.97 2023-07-12 4 M 0 12000 0 D 2014-07-16 2023-07-16 Common Stock 12000 0 I By SLAT Represents a "net exercise" of outstanding stock options. The Reporting Person received 5,338 shares of common stock on net exercise of an option to purchase 12,000 shares of common stock. The Reporting Person transferred this option to a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any. /s/ Lawrence Waldman 2023-07-19